Supplemental material
Open access
1,746
Views
0
CrossRef citations to date
0
Altmetric
Vaccine Safety
Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
Md Ahsan Habiba Clinical Sciences, Live Viral Vaccines, GSK, Wavre, BelgiumCorrespondence[email protected]
View further author information
, View further author information
Michael Poveyb Vaccines Biostats, GSK, Wavre, BelgiumView further author information
, Giacomo Casabonac Global Medical Affairs, GSK, Wavre, BelgiumView further author information
, Tina Singhd Global Safety, GSK, Wavre, BelgiumView further author information
& Remon Abu-Elyazeede Medical Affairs, GSK, Philadelphia, PA, USAView further author information
Article: 2188852
|
Received 14 Sep 2022, Accepted 06 Mar 2023, Published online: 29 Mar 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.